Literature DB >> 8719170

Intratracheally administered liposomal alpha-tocopherol protects the lung against long-term toxic effects of paraquat.

Z E Suntres1, P N Shek.   

Abstract

Paraquat is a broad-spectrum herbicide known to produce lung injury via oxidative stress-mediated mechanisms. Different pharmacological strategies have been explored to reduce the formation of these reactive oxygen species and/or prevent their toxic effects in the treatment of paraquat poisoning. The present study was carried out to investigate whether the antioxidant alpha-tocopherol, incorporated into liposomes and delivered directly to the lungs of rats, could protect the organ against the long-term toxic effects of paraquat. Plain liposomes (composed of dipalmitoylphosphatidylcholine, DPPC) or alpha-tocopherol liposomes (8 mg alpha-tocopherol/kg body weight) were administered intratracheally to animals 24 h prior to an intraperitoneal injection of paraquat dichloride (20 mg/kg) and rats were killed 0, 1, 4, 6, 8, 10, 12, 16, 19 or 24 days after paraquat treatment. Results of this study showed that lungs of animals treated with paraquat were extensively damaged, as evidenced by significant increases in lung weight and decreases in lung angiotensin converting enzyme (ACE) and alkaline phosphatase enzyme (AKP) activities. Moreover, paraquat treatment: resulted in a significant reduction in the number of neutrophils in the blood of rats with a concurrent increase in the pulmonary myeloperoxidase activity, suggestive of neutrophil infiltration in the lungs of treated animals. Pretreatment of rats with liposomes alone did not significantly alter the paraquat-induced changes of all parameters examined. On the other hand, pretreatment of rats with alpha-tocopherol liposomes, 24 h prior to paraquat challenge, attenuated paraquat-induced changes in ACE, AKP and myeloperoxidase activities but failed to prevent increases in lung weight. Thus, pretreatment of rats with liposome-associated alpha-tocopherol appears to protect the lung against some of the toxic effects of paraquat.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8719170

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  8 in total

Review 1.  Medical management of paraquat ingestion.

Authors:  Indika B Gawarammana; Nicholas A Buckley
Journal:  Br J Clin Pharmacol       Date:  2011-11       Impact factor: 4.335

Review 2.  Culprit or correlate? An application of the Bradford Hill criteria to Vitamin E acetate.

Authors:  Ryan Feldman; Jonathan Meiman; Matthew Stanton; David D Gummin
Journal:  Arch Toxicol       Date:  2020-05-25       Impact factor: 5.153

Review 3.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

4.  Protective Effects of Liposomal N-Acetylcysteine against Paraquat-Induced Cytotoxicity and Gene Expression.

Authors:  Panagiotis Mitsopoulos; Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-04-04

5.  Liposomal Antioxidants for Protection against Oxidant-Induced Damage.

Authors:  Zacharias E Suntres
Journal:  J Toxicol       Date:  2011-08-16

6.  Compiling Evidence for EVALI: A Scoping Review of In Vivo Pulmonary Effects After Inhaling Vitamin E or Vitamin E Acetate.

Authors:  Ryan Feldman; Matthew Stanton; Elizabeth M Suelzer
Journal:  J Med Toxicol       Date:  2021-02-02

7.  Prognostic comparison of goal-oriented hemoperfusion and routine hemoperfusion combined with continuous venovenous hemofiltration for paraquat poisoning.

Authors:  Xuming Zhao; Yan Xiao; Jianliang Zhu; Zhiping Xu; Lijun Liu; Jinsong Zhang
Journal:  J Int Med Res       Date:  2017-10-30       Impact factor: 1.671

8.  Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study.

Authors:  Wen-Pyng Wu; Ming-Nan Lai; Ching-Heng Lin; Yu-Fen Li; Ching-Yuang Lin; Ming-Ju Wu
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.